Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionAlps Advisors Inc
Latest Disclosed Ownership50,414 shares
Latest Disclosed Value $ 7,026,199
Alps Advisors Inc reports 6.83% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 50,414 shares of Gilead Sciences, Inc. (US:GILD) valued at $7,026,199 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 54,111 shares of Gilead Sciences, Inc.. This represents a change in shares of -6.83% during the quarter. The current value of the position is $6,502,902 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F GILEAD SCIENCES COM 375558103 50,414 -3,697 -6.83 7,026 5.80 0.0303
2026-02-12 2025-12-31 13F GILEAD SCIENCES COM 375558103 54,111 198 0.37 6,642 10.98 0.0387
2025-11-05 2025-09-30 13F GILEAD SCIENCES COM 375558103 53,913 34,083 171.88 5,984 172.25 0.0333
2025-08-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 19,830 2,234 12.70 2,199 11.52 0.0127
2025-04-30 2025-03-31 13F GILEAD SCIENCES COM 375558103 17,596 190 1.09 1,972 22.65 0.0114
2025-02-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 17,406 -291,007 -94.36 1,608 -93.79 0.0101
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 308,413 -84,455 -21.50 25,857 -4.07 0.1731
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 392,868 38,400 10.83 26,955 3.81 0.1850
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 354,468 24,189 7.32 25,965 -2.96 0.1838
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 330,279 -18,412 -5.28 26,756 2.39 0.2104
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 348,691 10,670 3.16 26,131 0.30 0.2169
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 338,021 -10,747 -3.08 26,051 -9.97 0.2263
2023-05-10 2023-03-31 13F GILEAD SCIENCES COM 375558103 348,768 22,189 6.79 28,937 3.21 0.2557
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 326,579 -93,658 -22.29 28,037 8.15 0.2501
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 420,237 -110,237 -20.78 25,924 -20.94 0.2453
2022-08-15 2022-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 530,474 113,539 27.23 32,789 32.28 0.3188
2022-08-11 2022-06-30 13F GILEAD SCIENCES COM 375558103 530,474 113,539 32,789 0.3139
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 416,935 80,853 24.06 24,787 1.57 0.2689
2022-02-09 2021-12-31 13F GILEAD SCIENCES COM 375558103 336,082 -444 -0.13 24,403 3.82 0.2746
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 336,526 -28,825 -7.89 23,506 -6.57 0.2265
2021-08-11 2021-06-30 13F GILEAD SCIENCES COM 375558103 365,351 -9,757 -2.60 25,158 3.77 0.2225
2021-05-07 2021-03-31 13F GILEAD SCIENCES COM 375558103 375,108 36,155 10.67 24,243 22.77 0.2368
2021-02-03 2020-12-31 13F GILEAD SCIENCES COM 375558103 338,953 59,664 21.36 19,747 11.89 0.2224
2020-11-05 2020-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 279,289 9,119 3.38 17,648 -15.10 0.2598
2020-11-04 2020-09-30 13F GILEAD SCIENCES COM 375558103 279,289 9,119 17,648 226,180.2629
2020-08-05 2020-06-30 13F GILEAD SCIENCES COM 375558103 270,170 -40,070 -12.92 20,787 -10.38 0.2787
2020-05-06 2020-03-31 13F GILEAD SCIENCES COM 375558103 310,240 -233,564 -42.95 23,194 -34.36 0.3588
2020-02-07 2019-12-31 13F GILEAD SCIENCES COM 375558103 543,804 6,135 1.14 35,337 3.69 0.2754
2019-11-04 2019-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 537,669 3,416 0.64 34,078 -5.59 0.2653
2019-08-07 2019-06-30 13F GILEAD SCIENCES COMMON STOCK 375558103 534,253 -60,185 -10.12 36,094 -6.60 0.2672
2019-05-01 2019-03-31 13F GILEAD SCIENCES COMMON STOCK 375558103 594,438 -25,712 -4.15 38,644 -0.38 0.2736
2019-02-04 2018-12-31 13F GILEAD SCIENCES COMMON STOCK 375558103 620,150 -47,101 -7.06 38,790 -24.71 0.3010
2018-10-25 2018-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 667,251 -25,839 -3.73 51,518 4.93 0.3380
2018-08-02 2018-06-30 13F/A-2 Gilead Sciences COMMON STOCK 375558103 693,090 53,152 8.31 49,098 1.77 0.3202
2018-07-31 2018-06-30 13F/A-1 Gilead Sciences COMMON STOCK 375558103 672,039 -21,051 48,145 0.3078
2018-07-25 2018-06-30 13F Gilead Sciences COMMON STOCK 375558103 672,039 32,101 48,145
2018-05-01 2018-03-31 13F Gilead Sciences COMMON STOCK 375558103 639,938 -32,101 -4.78 48,245 0.21 0.3839
2018-02-20 2017-12-31 13F/A-1 Gilead Sciences COMMON STOCK 375558103 672,039 646,350 2,516.06 48,145 2,213.55 0.3333
2018-02-05 2017-12-31 13F Gilead Sciences COMMON STOCK 375558103 672,039 646,350 48,145
2017-11-03 2017-09-30 13F Gilead Sciences COMMON STOCK 375558103 25,689 1,949 8.21 2,081 23.87 0.0147
2017-08-03 2017-06-30 13F Gilead Sciences COMMON STOCK 375558103 23,740 3,481 17.18 1,680 22.09 0.0117
2017-05-12 2017-03-31 13F Gilead Sciences COMMON STOCK 375558103 20,259 10,761 113.30 1,376 102.35 0.0095
2017-01-24 2016-12-31 13F Gilead Sciences Common Stock 375558103 9,498 1,353 16.61 680 5.59 0.0050
2016-11-02 2016-09-30 13F Gilead Sciences Common Stock 375558103 8,145 713 9.59 644 3.87 0.0053
2016-07-27 2016-06-30 13F Gilead Sciences Common Stock 375558103 7,432 2,661 55.77 620 41.55 0.0055
2016-05-10 2016-03-31 13F Gilead Sciences Common Stock 375558103 4,771 369 8.38 438 -1.57 0.0045
2016-02-05 2015-12-31 13F Gilead Sciences Common Stock 375558103 4,402 -100 -2.22 445 -89.93 0.0043
2015-11-13 2015-09-30 13F Gilead Sciences Common Stock 375558103 4,502 -755 -14.36 4,421 618.86 0.0047
2015-08-12 2015-06-30 13F GILEAD SCIENCES Common Stock 375558103 5,257 82 1.58 615 21.06 0.0052
2015-05-15 2015-03-31 13F GILEAD SCIENCES Common Stock 375558103 5,175 140 2.78 508 6.95 0.0042
2015-02-13 2014-12-31 13F GILEAD SCIENCES Common Stock 375558103 5,035 -682 -11.93 475 -22.00 0.0037
2014-12-18 2014-09-30 13F/A-1 GILEAD SCIENCES Common Stock 375558103 5,717 -2,150 -27.33 609 -6.60 0.0047
2014-11-24 2014-09-30 13F GILEAD SCIENCES Common Stock 375558103 5,717 609
2014-08-20 2014-06-30 13F/A-1 GILEAD SCIENCES Common Stock 375558103 7,867 200 2.61 652 20.07 0.0056
2014-08-15 2014-06-30 13F GENTEX Common Stock 375558103 19,188 558
2014-05-15 2014-03-31 13F GILEAD SCIENCES Common Stock 375558103 7,667 -23 -0.30 543 -12.42 0.0053
2014-02-11 2013-12-31 13F GILEAD SCIENCES Common Stock 375558103 7,690 3,710 93.22 620 148.00 0.0063
2013-11-13 2013-09-30 13F GILEAD SCIENCES Common Stock 375558103 3,980 3,980 250 0.0028
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.